Physician profile
Jill Walker
NPI 1750818100
$3,398.80
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,861 · 2022: $317 · 2023: $506 · 2024: $590 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,352.37 | 2021-2024 | Axonics |
| Abbvie INC. | $335.55 | 2021-2025 | |
| Astellas Pharma US INC | $153.79 | 2021 | |
| Abc Home Medical Supply, INC. | $150.37 | 2022-2024 | |
| Boston Scientific Corporation | $112.83 | 2022-2025 | Axonics, Upsylon |
| Urovant Sciences INC | $74.19 | 2022 | |
| Medtronic, INC. | $66.10 | 2022-2023 | Interstim |
| Coloplast Corp | $36.49 | 2021-2023 | Speedicath |
| Sumitomo Pharma America, INC. | $33.54 | 2023-2024 | Gemtesa |
| Pfizer INC. | $27.56 | 2024 | |
| Allergan, INC. | $24.74 | 2021 | |
| Glaxosmithkline, LLC. | $19.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.